Sermorelin — reference
GHRH analog, historically FDA-approved (Geref, now discontinued) and still compounded/prescribed off-label for GH support.
Regulatory status
Not FDA-Approved. No longer marketed as an FDA-approved product; typically obtained via a compounding pharmacy prescription.
Reported cautions
Pharmacokinetics
Published figures give an elimination half-life of ~10–20 minutes. GHRH(1-29) fragment; rapidly degraded, consistent with native GHRH's own short half-life.
This figure is tagged PK study in our evidence system. This figure comes from a published pharmacokinetic study rather than a label or registration trial. Sample sizes in such studies are often small and figures vary between them, so treat the number as a range rather than a constant. You can see the shape this implies between doses in the Half-Life Visualizer, and compare it against every other compound in the Half-Life Data Table. Our sourcing page explains what each tier means.
Remember that an estimated curve is a model built from a population figure, not a measurement of your blood. Individual clearance varies, and for depot injections the figure describes release from the injection site rather than the compound clearing. Half-life explained →
What Peptide Plug does and does not publish
This page carries regulatory status, general context and published pharmacokinetics. It carries no dose, frequency or cycle information — that is a deliberate editorial line, because dosing is a clinical decision rather than reference data. We also do not sell, supply, source or link to vendors for any compound.
Frequently asked
Is Sermorelin FDA-approved?
What is the half-life of Sermorelin?
How reliable is that half-life figure?
What cautions are associated with Sermorelin?
Does Peptide Plug publish dosing for Sermorelin?
Does Peptide Plug sell Sermorelin?
Related tools
Free, no account required.
The public research page intentionally does not publish dosing. Pro subscribers can open the separate Protocol Library for structured indication, frequency, duration, notes, and review-first Cycle Builder import when a matching reference is available.
View Protocol Reference